These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. HLA DR4 is a marker for rapid disease progression in primary sclerosing cholangitis. Mehal WZ; Lo YM; Wordsworth BP; Neuberger JM; Hubscher SC; Fleming KA; Chapman RW Gastroenterology; 1994 Jan; 106(1):160-7. PubMed ID: 8276178 [TBL] [Abstract][Full Text] [Related]
5. Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors. Donaldson PT; Doherty DG; Hayllar KM; McFarlane IG; Johnson PJ; Williams R Hepatology; 1991 Apr; 13(4):701-6. PubMed ID: 2010165 [TBL] [Abstract][Full Text] [Related]
6. HLA antigens in Japanese patients with primary biliary cirrhosis and autoimmune hepatitis. Miyamori H; Kato Y; Kobayashi K; Hattori N Digestion; 1983; 26(4):213-7. PubMed ID: 6409699 [TBL] [Abstract][Full Text] [Related]
8. HLA DPB polymorphism in primary sclerosing cholangitis and primary biliary cirrhosis. Underhill JA; Donaldson PT; Doherty DG; Manabe K; Williams R Hepatology; 1995 Apr; 21(4):959-62. PubMed ID: 7705806 [TBL] [Abstract][Full Text] [Related]
9. Extended major histocompatibility complex haplotypes in type I diabetes mellitus. Raum D; Awdeh Z; Yunis EJ; Alper CA; Gabbay KH J Clin Invest; 1984 Aug; 74(2):449-54. PubMed ID: 6746903 [TBL] [Abstract][Full Text] [Related]
10. Major histocompatibility complex class I to III allotypes in patients with AIDS-related complex/Walter-Reed 5, disseminated Kaposi's sarcoma and in normal controls. The ARC-IVIG Study Group. Plum G; Siebel E; Bendick C; Rasokat H; Braun M; Krickeberg H; Mauff G Vox Sang; 1990; 59 Suppl 1():15-20. PubMed ID: 2238573 [TBL] [Abstract][Full Text] [Related]
11. The molecular genetics of autoimmune liver disease. Donaldson P; Doherty D; Underhill J; Williams R Hepatology; 1994 Jul; 20(1 Pt 1):225-39. PubMed ID: 8020893 [TBL] [Abstract][Full Text] [Related]
12. HLA associations with autoimmune-type chronic active hepatitis: identification of B8-DRw3 haplotype by family studies. Mackay IR; Tait BD Gastroenterology; 1980 Jul; 79(1):95-8. PubMed ID: 7380229 [TBL] [Abstract][Full Text] [Related]
13. Complement and HLA. Further definition of high-risk haplotypes in insulin-dependent diabetes. Rich S; O'Neill G; Dalmasso AP; Nerl C; Barbosa J Diabetes; 1985 May; 34(5):504-9. PubMed ID: 3987976 [TBL] [Abstract][Full Text] [Related]
14. [The clinical immunogenetics of viral hepatitis C in a Caucasoid population of western Siberia]. Tolokonskaia NP; Konenkov VI Zh Mikrobiol Epidemiol Immunobiol; 2000; (3):78-80. PubMed ID: 10925885 [TBL] [Abstract][Full Text] [Related]
15. HLA DRw8 and complement C4 deficiency as risk factors in primary biliary cirrhosis. Manns MP; Bremm A; Schneider PM; Notghi A; Gerken G; Prager-Eberle M; Stradmann-Bellinghausen B; Meyer zum Büschenfelde KH; Rittner C Gastroenterology; 1991 Nov; 101(5):1367-73. PubMed ID: 1936808 [TBL] [Abstract][Full Text] [Related]
17. [Reactivity to hepatitis B vaccination (HBV) in patients with uremia: association with defined HLA antigen configuration and complement protein allotypes C4A, C4B and B factor (Bf)]. Stachowski J; Runowski D; Kramer J; Madaliński K; Maciejewski J; Baldamus CA Przegl Lek; 1995; 52(9):445-54. PubMed ID: 8834646 [TBL] [Abstract][Full Text] [Related]
19. Molecular heterogeneity of second and fourth components of complement and their genes in systemic sclerosis and association of HLA alleles A1, B8 and DR3 with limited and DR5 with diffuse systemic sclerosis. Venneker GT; van den Hoogen FH; van Meegen M; de Kok-Nazaruk M; Hulsmans RF; Boerbooms AM; de Waal LP; Bos JD; Asghar SS Exp Clin Immunogenet; 1998; 15(2):90-9. PubMed ID: 9691203 [TBL] [Abstract][Full Text] [Related]
20. Early-onset autoimmune hepatitis is associated with a C4A gene deletion. Scully LJ; Toze C; Sengar DP; Goldstein R Gastroenterology; 1993 May; 104(5):1478-84. PubMed ID: 8482459 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]